← All stocks

Nurix Therapeutics, Inc.

NRIX Mostly scheduled
CIK 0001549595 #1793 in the set updated 17 Sep 2026
Bought (120 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$13.90M
$2.89M on a plan · $10.80M straight out of an exercise
Sold at will
$210.74K
22 of 191 sales
Net
−$13.90M
−$210.74K against sales at will

By person

12 insiders · 196 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Ring Christine
Chief Legal Officer
$5.97M (78) scheduled
−$5.97M
9,110
0.0088%
$242.67K
+125.0%
van Houte Hans
Chief Financial Officer
$4.62M (45) scheduled
−$4.62M
40,166
0.0387%
$1.07M
Beaurang Pierre
Chief Business Officer
$1.84M (21) scheduled
−$1.84M
120,996
0.1166%
$3.22M
+3.7%
Hansen Gwenn
Chief Scientific Officer
$1.45M (42) scheduled
−$1.45M
117,227
0.1130%
$3.12M
+2,451%
Wolff Stefani
EVP and COO
$22.34K (5)
−$22.34K
6,113
0.0059%
$162.84K
+96.9%
Third Rock Ventures III, L.P. entity
10% owner
3,509,348
3.38%
$93.48M
+3,943%
COLUMN GROUP L P entity
10% owner
2,080,607
2.00%
$55.42M
Redmile Group, LLC entity
10% owner
1,176,470
1.13%
$31.34M
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% owner
784,313
0.7557%
$20.89M
Tjian Robert
Director
124,999
0.1204%
$3.33M
+275.0%
GREGORY JULIA P
Director
10,750
0.0104%
$286.35K
Kunkel Lori Anne
Director
0
0.0000%
$0.00
−100.0%
Insider
Date
Role
Action
Shares
Price
Amount
van Houte Hans
4 Aug 2026
Chief Financial Officer
Sold on a plan
2,967
$24.65
$73.13K
van Houte Hans
4 Aug 2026
Chief Financial Officer
Sold on a plan
1,794
$23.89
$42.86K
Hansen Gwenn
4 Aug 2026
Chief Scientific Officer
Sold on a plan
2,611
$24.64
$64.34K
Hansen Gwenn
4 Aug 2026
Chief Scientific Officer
Sold on a plan
1,500
$23.87
$35.80K
Hansen Gwenn
25 Jun 2026
Chief Scientific Officer
Sold on a plan
5,394
$20.00
$107.88K
van Houte Hans
5 May 2026
Chief Financial Officer
Sold on a plan
582
$17.18
$10.00K
van Houte Hans
5 May 2026
Chief Financial Officer
Sold on a plan
13,473
$16.58
$223.32K
Ring Christine
4 May 2026
Chief Legal Officer
Sold on a plan
8,148
$16.96
$138.21K
Ring Christine
1 May 2026
Chief Legal Officer
Sold on a plan
5,394
$16.76
$90.41K
Ring Christine
2 Apr 2026
Chief Legal Officer
Sold on a plan
8,148
$15.24
$124.15K
Ring Christine
2 Mar 2026
Chief Legal Officer
Sold on a plan
8,148
$15.44
$125.79K
Ring Christine
9 Feb 2026
Chief Legal Officer
Sold on a plan
14,261
$16.66
$237.62K
van Houte Hans
3 Nov 2025
Chief Financial Officer
Sold on a plan
6,284
$12.56
$78.93K
van Houte Hans
1 Aug 2025
Chief Financial Officer
Sold on a plan
5,402
$11.03
$59.60K
van Houte Hans
2 May 2025
Chief Financial Officer
Sold on a plan
6,198
$11.33
$70.24K
van Houte Hans
3 Mar 2025
Chief Financial Officer
Sold on a plan
700
$15.13
$10.59K
van Houte Hans
3 Mar 2025
Chief Financial Officer
Sold on a plan
5,125
$14.40
$73.80K
van Houte Hans
1 Nov 2024
Chief Financial Officer
Sold on a plan
3,546
$24.28
$86.08K
van Houte Hans
26 Aug 2024
Chief Financial Officer
Sold on a plan
20,000
$25.22
$504.37K
van Houte Hans
1 Aug 2024
Chief Financial Officer
Sold on a plan
100
$22.22
$2.22K
van Houte Hans
1 Aug 2024
Chief Financial Officer
Sold on a plan
3,377
$21.43
$72.35K
van Houte Hans
20 Jun 2024
Chief Financial Officer
Sold on a plan
20,000
$20.01
$400.22K
van Houte Hans
2 May 2024
Chief Financial Officer
Sold on a plan
3,499
$12.83
$44.88K
van Houte Hans
16 Feb 2024
Chief Financial Officer
Sold on a plan
6,812
$10.02
$68.22K
van Houte Hans
20 Dec 2023
Chief Financial Officer
Sold on a plan
3,541
$10.00
$35.42K
van Houte Hans
19 Dec 2023
Chief Financial Officer
Sold on a plan
10,906
$10.00
$109.09K

What was left out

Form 4 filings counted 242
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 143
Sales at will 22
Transactions with no price 0
Shares from compensation/vesting 32,280,499
Sales filed before the plan box existed 12
History held since 29 Jul 2020